UroMems announced that the entire treatment cohort in the first-of-its-kind study in female patients successfully reached its primary endpoints. Grenoble, France-based UroMems — which has its U.S. headquarters in Minneapolis — develops an implantable system called UroActive. Powered by a MyoElectroMechanical system (MEMS), UroActive goes into the urethral duct in men and bladder neck in […]
UroMems
The top 10 urology device stories of 2024 so far
Urology Week 2024, which closes out The Urology Foundation’s Urology Awareness Month, is a good time to highlight the innovations in this space. This week (Sept. 23-29), is an initiative of the European Association of Urology that brings together national urological societies, urology practitioners, urology nurses, patients and their families, and politicians to create awareness of urological […]
UroMems raises $47M Series C
UroMems announced that it raised $47 million in a Series C financing to support clinical trials for its smart automated artificial urinary sphincter (AUS). Grenoble, France-based UroMems — which has its U.S. headquarter in Minneapolis — developed the AUS to treat stress urinary incontinence (SUI). It expects the funds to support large-scale U.S. and European […]
UroMems has positive results for first-ever female implant of smart urinary sphincter system
UroMems announced today that it successfully met the six-month primary endpoint for the first female patient implanted with UroActive. Grenoble, France-based UroMems designed its smart UroActive implant to treat stress urinary incontinence (SUI). The company says it’s the first smart, automated artificial urinary sphincter (AUS) to treat SUI. Powered by a MyoElectroMechanical system (MEMS), UroActive […]
UroMems reports positive feasibility data for smart urology implant
UroMems today announced that it the treatment cohort in a feasibility study of its UroActive system reached six-month primary endpoints. Grenoble, France-based UroMems designed its smart UroActive implant to treat stress urinary incontinence (SUI). The company says it’s the first smart, automated artificial urinary sphincter (AUS) to treat SUI. Powered by a MyoElectroMechanical system (MEMS), […]
UroMems completes first-in-human study enrollment for smart urinary implant
UroMems announced today that it successfully completed enrollment in its first-in-human study of its UroActive system. Grenoble, France-based UroMems designed the UroActiv system as a smart, automated artificial urinary sphincter (AUS). It treats stress urinary incontinence (SUI). Results from the initial study should support the design and implementation of a pivotal trial in Europe and […]
Smart implant from UroMems meets primary endpoint in first-in-human study
UroMems announced that it successfully met the primary endpoints for the initial male patient in a study of its UroActive smart implant. Grenoble, France-based UroMems develops mechatronics technology to treat stress urinary incontinence (SUI). Its SOPHIA study evaluates the UroActive smart, automated artificial urinary sphincter (AUS) in the treatment of SUI. The company plans for […]
UroMems picks up FDA STeP designation for smart implant that treats urinary incontinence
UroMems announced that it received Safer Technologies Program (STeP) designation from the FDA for its UroActive smart continence therapy. STeP, a collaborative program, helps reduce the time needed to develop and obtain marketing authorization for eligible devices. FDA launched STeP in 2021, modeling the program on its breakthrough devices designation program. STeP covers devices that […]
UroMems begins first-in-human study of smart implant for treating stress urinary incontinence
UroMems announced today that it completed the first-in-human implant of its UroActive system for treating stress urinary incontinence (SUI). Grenoble, France-based UroMems designed UroActive as a smart, automated artificial urinary sphincter (AUS) investigational device. The company said in a news release that UroActive represents the first smart, automated AUS. Kicking off the clinical study marks […]
UroMems adds $8.3M, brings Series B round to $27.3M
UroMems announced today that it added $8.3 million to its Series B financing round, bringing the total funds raised to $27.3 million. Grenoble, France-based UroMems’ $27.3 million (€23 million) financing round had its first tranche completed in May 2020 but added the $8.3 million (€7 million) thanks to existing investors including Hil-Invent GmbH, Financière Arbevel, […]
UroMems raises $17.6m
Electronic artificial urinary sphincter (eAUS) maker UroMems announced today that it raised $17.6 million (€16 million) in an equity and debt financing. Grenoble, France-based UroMems intends to use the proceeds from the funding to support ongoing preclinical studies and the initiation of the first clinical studies of its eAUS device for treating stress urinary incontinence […]